{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T12:52:42Z","timestamp":1784983962547,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00259-015-3187-2","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T09:42:18Z","timestamp":1442569338000},"page":"482-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Influence of 18F-FDG PET\/CT on therapy management in patients with stage III\/IV malignant melanoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Susann-Cathrin","family":"Sch\u00fcle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Kurt","family":"Eigentler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"la Foug\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pfannenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"issue":"36","key":"3187_CR1","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199\u2013206.","journal-title":"J Clin Oncol"},{"issue":"26","key":"3187_CR2","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364(26):2507\u201316.","journal-title":"N Engl J Med"},{"issue":"8","key":"3187_CR3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711\u201323.","journal-title":"N Engl J Med"},{"issue":"3","key":"3187_CR4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/bjc.2012.306","volume":"107","author":"B Weide","year":"2012","unstructured":"Weide B, Elsasser M, Buttner P, Pflugfelder A, Leiter U, Eigentler TK, et al. Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis. Br J Cancer. 2012;107(3):422\u20138.","journal-title":"Br J Cancer"},{"issue":"1","key":"3187_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.soc.2010.09.010","volume":"20","author":"AS Caudle","year":"2011","unstructured":"Caudle AS, Ross MI. Metastasectomy for stage IV melanoma: for whom and how much? Surg Oncol Clin N Am. 2011;20(1):133\u201344.","journal-title":"Surg Oncol Clin N Am"},{"issue":"Suppl 6","key":"3187_CR6","first-page":"1","volume":"11","author":"A Pflugfelder","year":"2013","unstructured":"Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, et al. Malignant melanoma S3-guideline \u201cdiagnosis, therapy and follow-up of melanoma\u201d. J Dtsch Dermatol Ges. 2013;11 Suppl 6:1\u2013116.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"8","key":"3187_CR7","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-012-2399-y","volume":"19","author":"BB Kroon","year":"2012","unstructured":"Kroon BB. Surgery for distant metastatic melanoma improves survival. Ann Surg Oncol. 2012;19(8):2426\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"3187_CR8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","volume":"351","author":"H Tsao","year":"2004","unstructured":"Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004;351(10):998\u20131012.","journal-title":"N Engl J Med"},{"key":"3187_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","volume":"103","author":"Y Xing","year":"2011","unstructured":"Xing Y, Bronstein Y, Merrick I. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011;103:129\u201342.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3187_CR10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejca.2006.11.014","volume":"43","author":"C Pfannenberg","year":"2007","unstructured":"Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007;43(3):557\u201364.","journal-title":"Eur J Cancer"},{"key":"3187_CR11","volume-title":"R: a language and environment for statistical computing","author":"R Development Core Team","year":"2014","unstructured":"R Development Core Team. R: a language and environment for statistical computing. 31st ed. Vienna: R Foundation for Statistical Computing; 2014.","edition":"31"},{"issue":"20","key":"3187_CR12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","volume":"371","author":"J Larkin","year":"2014","unstructured":"Larkin J, Ascierto PA, Dreno B, Atkinson V, Liszkay G, Maio M, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med. 2014;371(20):1867\u201376.","journal-title":"N Engl J Med"},{"issue":"20","key":"3187_CR13","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","volume":"371","author":"GV Long","year":"2014","unstructured":"Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, et al. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med. 2014;371(20):1877\u201388.","journal-title":"N Engl J Med"},{"issue":"2","key":"3187_CR14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med. 2012;367(2):107\u201314.","journal-title":"N Engl J Med"},{"issue":"4","key":"3187_CR15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015;372(4):320\u201330.","journal-title":"N Engl J Med"},{"issue":"1","key":"3187_CR16","first-page":"17","volume":"4","author":"M Danielsen","year":"2013","unstructured":"Danielsen M, Hojgaard L, Kjaer A, Fischer BM. Positron emission tomography in the follow-up of cutaneous malignant melanoma patients: a systematic review. Am J Nucl Med Mol Imaging. 2013;4(1):17\u201328.","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"4","key":"3187_CR17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2214\/AJR.11.7280","volume":"198","author":"Y Bronstein","year":"2012","unstructured":"Bronstein Y, Ng CS, Rohren E, Ross MI, Lee JE, Cormier J, et al. PET\/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. AJR Am J Roentgenol. 2012;198(4):902\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"3187_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.semnuclmed.2015.03.006","volume":"45","author":"N Schwenzer","year":"2015","unstructured":"Schwenzer N, Pfannenberg C. PET\/CT, MR and PET\/MR in lymphoma and melanoma. Semin Nucl Med. 2015;45(4):322\u201331.","journal-title":"Semin Nucl Med"},{"issue":"2","key":"3187_CR19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00117-014-2762-z","volume":"55","author":"C Pfannenberg","year":"2015","unstructured":"Pfannenberg C, Schwenzer N. Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole body MRI and PET-MRI. Radiologe. 2015;55(2):120\u20136.","journal-title":"Radiologe"},{"key":"3187_CR20","first-page":"212","volume":"9","author":"D Hausmann","year":"2011","unstructured":"Hausmann D, Jochum S, Utikal J, Hoffmann RC, Zechmann C, Neff KW, et al. Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III\/IV malignant melanoma. J Dtsch Dermatol Ges. 2011;9:212\u201322.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"3187_CR21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejrad.2009.04.059","volume":"75","author":"V Laurent","year":"2010","unstructured":"Laurent V, Trausch G, Bruot O, Olivier P, Felbinger J, R\u00e9gent D. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT. Eur J Radiol. 2010;75(3):376\u201383.","journal-title":"Eur J Radiol"},{"issue":"4","key":"3187_CR22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1010-7940(02)00026-X","volume":"21","author":"MJR Dalrymple-Hay","year":"2002","unstructured":"Dalrymple-Hay MJR, Rome PD, Kennedy C, Fullham M, Cuaghan BC. Pulmonary metastatic malanoma \u2013 the survival benefit of positron emission tomography scanning. Eur J Cardiothorac Surg. 2002;21(4):611\u20135.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"3187_CR23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/CMR.0b013e3283632cbe","volume":"23","author":"R Younes","year":"2013","unstructured":"Younes R, Abrao FC, Gross J. Pulmonary metastasectomy for malignant melanoma: prognostic factors for long-term survival. Melanoma Res. 2013;23(4):307\u201311.","journal-title":"Melanoma Res"},{"issue":"4","key":"3187_CR24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/CMR.0000000000000076","volume":"24","author":"MW Colman","year":"2014","unstructured":"Colman MW, Kirkwood JM, Schott T, Goodman MA, McGough 3rd RL. Does metastasectomy improve survival in skeletal melanoma? Melanoma Res. 2014;24(4):354\u20139.","journal-title":"Melanoma Res"},{"issue":"8","key":"3187_CR25","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1245\/s10434-012-2398-z","volume":"19","author":"JH Howard","year":"2012","unstructured":"Howard JH, Thompson JF, Mozzillo N, Nieweg OE, Hoekstra HJ, Roses DF, et al. Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol. 2012;19(8):2547\u201355.","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3187-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3187-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3187-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T00:18:46Z","timestamp":1653178726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3187-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3187"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3187-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,18]]}}}